WHO Approves Two Experimental Ebola Vaccines For Testing In West Africa But Declining Case Numbers Could Complicate Trials

CIDRAP: WHO experts chart next steps for Ebola vaccine trials (Schnirring, 1/9).
Bloomberg News: Glaxo, Merck Ebola Vaccine Trials to Start in West Africa (Bennett, 1/9).
Deutsche Welle: WHO announces ‘good news’ for Ebola vaccine (1/9).
New York Times: In Africa, a Decline in New Ebola Cases Complicates Vaccine Development (Pollack, 1/9).
NPR: Ebola Vaccine Will Soon Be Tested In West Africa (Harris, 1/9).
U.N. News Centre: Two leading Ebola vaccines show ‘acceptable safety’ — U.N. health agency (1/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.